Inspire Investing LLC Sells 572 Shares of Equifax Inc. (NYSE:EFX)

Inspire Investing LLC trimmed its stake in Equifax Inc. (NYSE:EFXFree Report) by 34.4% during the second quarter, HoldingsChannel.com reports. The fund owned 1,089 shares of the credit services provider’s stock after selling 572 shares during the quarter. Inspire Investing LLC’s holdings in Equifax were worth $264,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. UBS Group AG increased its position in shares of Equifax by 26.6% during the 4th quarter. UBS Group AG now owns 98,987 shares of the credit services provider’s stock worth $24,478,000 after purchasing an additional 20,775 shares in the last quarter. D.A. Davidson & CO. acquired a new stake in shares of Equifax during the fourth quarter worth approximately $236,000. Corient Private Wealth LLC raised its stake in shares of Equifax by 7.7% in the fourth quarter. Corient Private Wealth LLC now owns 22,194 shares of the credit services provider’s stock valued at $5,488,000 after acquiring an additional 1,593 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Equifax by 74.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 9,890 shares of the credit services provider’s stock worth $2,446,000 after acquiring an additional 4,233 shares in the last quarter. Finally, US Bancorp DE grew its position in Equifax by 5.4% during the 4th quarter. US Bancorp DE now owns 13,369 shares of the credit services provider’s stock worth $3,307,000 after acquiring an additional 683 shares during the last quarter. 96.20% of the stock is currently owned by institutional investors and hedge funds.

Equifax Stock Up 0.3 %

Shares of Equifax stock opened at $300.33 on Wednesday. Equifax Inc. has a 1 year low of $159.95 and a 1 year high of $309.63. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market capitalization of $37.12 billion, a P/E ratio of 66.89, a price-to-earnings-growth ratio of 1.99 and a beta of 1.58. The business has a 50-day moving average of $289.51 and a two-hundred day moving average of $259.67.

Equifax (NYSE:EFXGet Free Report) last announced its earnings results on Wednesday, July 17th. The credit services provider reported $1.82 EPS for the quarter, topping the consensus estimate of $1.73 by $0.09. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.42 billion. Equifax had a net margin of 10.67% and a return on equity of 18.88%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the company posted $1.71 EPS. As a group, equities analysts predict that Equifax Inc. will post 7.33 EPS for the current year.

Equifax Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Tuesday, September 3rd were paid a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 0.52%. The ex-dividend date was Tuesday, September 3rd. Equifax’s dividend payout ratio is 34.74%.

Insider Buying and Selling at Equifax

In related news, EVP Carla Chaney sold 3,000 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total transaction of $845,550.00. Following the completion of the transaction, the executive vice president now directly owns 10,875 shares in the company, valued at $3,065,118.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.57% of the company’s stock.

Wall Street Analysts Forecast Growth

EFX has been the topic of a number of recent analyst reports. The Goldman Sachs Group boosted their price objective on Equifax from $277.00 to $307.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 20th. JPMorgan Chase & Co. upped their price target on shares of Equifax from $273.00 to $300.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Barclays increased their price objective on shares of Equifax from $300.00 to $380.00 and gave the stock an “overweight” rating in a report on Friday, September 13th. Robert W. Baird boosted their target price on shares of Equifax from $260.00 to $290.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Finally, Wolfe Research initiated coverage on shares of Equifax in a research note on Tuesday, July 9th. They set an “outperform” rating and a $275.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Equifax currently has an average rating of “Moderate Buy” and an average price target of $302.06.

View Our Latest Analysis on EFX

About Equifax

(Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Read More

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFXFree Report).

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.